These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 24353161)

  • 1. Cancer nanomedicine: from drug delivery to imaging.
    Chow EK; Ho D
    Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.
    Liang C; Xu L; Song G; Liu Z
    Chem Soc Rev; 2016 Nov; 45(22):6250-6269. PubMed ID: 27333329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanodiamond-based chemotherapy and imaging.
    Ho D
    Cancer Treat Res; 2015; 166():85-102. PubMed ID: 25895865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoparticles for multimodal imaging and theragnosis.
    Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC
    Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
    Wicki A; Witzigmann D; Balasubramanian V; Huwyler J
    J Control Release; 2015 Feb; 200():138-57. PubMed ID: 25545217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine applied to translational oncology: A future perspective on cancer treatment.
    Bregoli L; Movia D; Gavigan-Imedio JD; Lysaght J; Reynolds J; Prina-Mello A
    Nanomedicine; 2016 Jan; 12(1):81-103. PubMed ID: 26370707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional nanoparticles for targeting cancer and inflammatory diseases.
    Jain S; Doshi AS; Iyer AK; Amiji MM
    J Drug Target; 2013 Dec; 21(10):888-903. PubMed ID: 24024598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-Organic Framework-Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging.
    Cai W; Chu CC; Liu G; Wáng YX
    Small; 2015 Oct; 11(37):4806-22. PubMed ID: 26193176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation.
    Lao YH; Phua KK; Leong KW
    ACS Nano; 2015 Mar; 9(3):2235-54. PubMed ID: 25731717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosize, mega-impact, potential for medical applications of nanotechnology.
    Ashammakhi N
    J Craniofac Surg; 2006 Jan; 17(1):3-7. PubMed ID: 16432397
    [No Abstract]   [Full Text] [Related]  

  • 15. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy.
    Doane TL; Burda C
    Chem Soc Rev; 2012 Apr; 41(7):2885-911. PubMed ID: 22286540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
    Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering imaging probes and molecular machines for nanomedicine.
    Tong S; Cradick TJ; Ma Y; Dai Z; Bao G
    Sci China Life Sci; 2012 Oct; 55(10):843-61. PubMed ID: 23108862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.